相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulation of Wnt Signaling Pathways at the Plasma Membrane and Their Misregulation in Cancer
Yagmur Azbazdar et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Comprehensive Review of Methodology to Detect Reactive Oxygen Species (ROS) in Mammalian Species and Establish Its Relationship with Antioxidants and Cancer
Shivkanya Fuloria et al.
ANTIOXIDANTS (2021)
Adaptive phenotypic modulations lead to therapy resistance in chronic myeloid leukemia cells
Seda Baykal-Kose et al.
PLOS ONE (2020)
Maternal Embryonic Leucine Zipper Kinase Promotes Tumor Growth and Metastasis via Stimulating FOXM1 Signaling in Esophageal Squamous Cell Carcinoma
Liang Chen et al.
FRONTIERS IN ONCOLOGY (2020)
Phenotypic screening using large-scale genomic libraries to identify drug targets for the treatment of cancer
Mitsuo Sato
ONCOLOGY LETTERS (2020)
Prediction of lymph node metastasis by tumor-infiltrating lymphocytes in T1 breast cancer
Koji Takada et al.
BMC CANCER (2020)
Anti-EGFR therapy in metastatic colorectal cancer: mechanisms and potential regimens of drug resistance
Qing-Hai Li et al.
GASTROENTEROLOGY REPORT (2020)
Wnt/β-catenin Signaling in Tissue Self-Organization
Kelvin W. Pond et al.
GENES (2020)
Notch Signaling in Breast Cancer: A Role in Drug Resistance
McKenna BeLow et al.
CELLS (2020)
Discovery of a novel EGFR ligand DPBA that degrades EGFR and suppresses EGFR-positive NSCLC growth
Nan Yao et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
RANKL biology: bone metabolism, the immune system, and beyond
Takehito Ono et al.
INFLAMMATION AND REGENERATION (2020)
Targeting cancer stem cell pathways for cancer therapy
Liqun Yang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Twin CHCH Proteins, CHCHD2, and CHCHD10: Key Molecules of Parkinson's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia
Yuzuru Imai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Misactivation of Hedgehog signaling causes inherited and sporadic cancers
David R. Raleigh et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Skin tissue engineering: wound healing based on stem-cell-based therapeutic strategies
Azar Nourian Dehkordi et al.
STEM CELL RESEARCH & THERAPY (2019)
The Roles of MicroRNA in Lung Cancer
Kuan-Li Wu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery
Giacomo Pata et al.
JOURNAL OF SURGICAL RESEARCH (2019)
Concurrent EGFR-TKI and Thoracic Radiotherapy as First-Line Treatment for Stage IV Non-Small Cell Lung Cancer Harboring EGFR Active Mutations
Linpeng Zheng et al.
ONCOLOGIST (2019)
Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype
M. V. Giuli et al.
JOURNAL OF ONCOLOGY (2019)
Wnt, Notch, and TGF-β Pathways Impinge on Hedgehog Signaling Complexity: An Open Window on Cancer
Maria Pelullo et al.
FRONTIERS IN GENETICS (2019)
Targeting Autophagy for Overcoming Resistance to Anti-EGFR Treatments
Yoojung Kwon et al.
CANCERS (2019)
Rethink of EGFR in Cancer With Its Kinase Independent Function on Board
Rintu Thomas et al.
FRONTIERS IN ONCOLOGY (2019)
Impact of EGFR-TKIs combined with PD-L1 antibody on the lung tissue of EGFR-driven tumor-bearing mice
Yijun Jia et al.
LUNG CANCER (2019)
Molecular Targeting Therapy against EGFR Family in Breast Cancer: Progress and Future Potentials
Amaia Eleonora Maennling et al.
CANCERS (2019)
Emerging functions of the EGFR in cancer
Sara Sigismund et al.
MOLECULAR ONCOLOGY (2018)
Combination Strategies Using EGFR-TKi in NSCLC Therapy: Learning from the Gap between Pre-Clinical Results and Clinical Outcomes
Zheng Yang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
Neat I. Lindeman et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2018)
Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology
Amy E. McCart Reed et al.
JOURNAL OF PATHOLOGY (2018)
Molecular Subtypes and Local-Regional Control of Breast Cancer
Simona Maria Fragomeni et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2018)
The Notch Pathway in Breast Cancer Progression
Emmanuel N. Kontomanolis et al.
TheScientificWorldJOURNAL (2018)
Combined small-cell lung carcinoma
Jing Qin et al.
ONCOTARGETS AND THERAPY (2018)
The Notch Pathway in Breast Cancer Progression
Emmanuel N. Kontomanolis et al.
Scientific World Journal (2018)
The Oncojanus Paradigm of Respiratory Complex I
Giulia Leone et al.
GENES (2018)
Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib After Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients With EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung Cancer
Yi-Long Wu et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Interplay between NRF1, E2F4 and MYC transcription factors regulating common target genes contributes to cancer development and progression
Kaumudi Bhawe et al.
CELLULAR ONCOLOGY (2018)
EGFR is required for FOS-dependent bone tumor development via RSK2/CREB signaling
Markus Linder et al.
EMBO MOLECULAR MEDICINE (2018)
The genetic basis of disease
Maria Jackson et al.
UNDERSTANDING BIOCHEMISTRY 4 (2018)
Role of Epidermal Growth Factor Receptor (EGFR) and Its Ligands in Kidney Inflammation and Damage
Sandra Rayego-Mateos et al.
MEDIATORS OF INFLAMMATION (2018)
Mitochondrial disorders
Shibani Kanungo et al.
ANNALS OF TRANSLATIONAL MEDICINE (2018)
Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis
Yixiao Feng et al.
GENES & DISEASES (2018)
Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis
Sun-Wei Guo
REPRODUCTIVE MEDICINE AND BIOLOGY (2018)
Fatty acid oxidation disorders
J. Lawrence Merritt et al.
ANNALS OF TRANSLATIONAL MEDICINE (2018)
Osimertinib for the treatment of patients with EGFR mutation-positive non-small cell lung cancer
M. Alsharedi et al.
DRUGS OF TODAY (2018)
Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines
Silvia La Monica et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Epigenetics in cancer stem cells
Tan Boon Toh et al.
MOLECULAR CANCER (2017)
Overview of Cancer Stem Cells and Stemness for Community Oncologists
Justin D. Lathia et al.
TARGETED ONCOLOGY (2017)
Role of Delta-like 4 in Jagged1-induced tumour angiogenesis and tumour growth
Chern Ein Oon et al.
ONCOTARGET (2017)
Contributions of MET activation to BCR-ABL1 tyrosine kinase inhibitor resistance in chronic myeloid leukemia cells
Masanobu Tsubaki et al.
ONCOTARGET (2017)
Multiple receptor tyrosine kinase activation related to ALK inhibitor resistance in lung cancer cells with ALK rearrangement
Se Hoon Choi et al.
ONCOTARGET (2017)
The prediction models for postoperative overall survival and disease-free survival in patients with breast cancer
Daichi Shigemizu et al.
CANCER MEDICINE (2017)
Lung neuroendocrine tumors: pathological characteristics
Luisella Righi et al.
JOURNAL OF THORACIC DISEASE (2017)
Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
Ping Wee et al.
CANCERS (2017)
The Landscape of mtDNA Modifications in Cancer: A Tale of Two Cities
Kate L. Hertweck et al.
FRONTIERS IN ONCOLOGY (2017)
Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis
Kylie L. Gorringe et al.
FRONTIERS IN ONCOLOGY (2017)
Diseases and Molecular Diagnostics: A Step Closer to Precision Medicine
Shailendra Dwivedi et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2017)
The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells
Farhad Seif et al.
CELL COMMUNICATION AND SIGNALING (2017)
The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia
Marta Sanchez-Martin et al.
BLOOD (2017)
Lung cancer in which the hypothesis of multi-step progression is confirmed by array-CGH results: A case report
Daniela Bettio et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
Dasatinib induces DNA damage and activates DNA repair pathways leading to senescence in non-small cell lung cancer cell lines with kinase-inactivating BRAF mutations
Shaohua Peng et al.
ONCOTARGET (2016)
Rational prescribing: the principles of drug selection
Simon R. J. Maxwell
CLINICAL MEDICINE (2016)
Sudden infant death syndrome caused by cardiac arrhythmias: only a matter of genes encoding ion channels?
Georgia Sarquella-Brugada et al.
INTERNATIONAL JOURNAL OF LEGAL MEDICINE (2016)
Study of Gefitinib and Pemetrexed as First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation
Chaolun An et al.
PATHOLOGY & ONCOLOGY RESEARCH (2016)
PARP inhibitors: review of mechanisms of action and BRCA1/2 mutation targeting
Karolina N. Dziadkowiec et al.
MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY (2016)
Stress-Induced EGFR Trafficking: Mechanisms, Functions, and Therapeutic Implications
Xiaojun Tan et al.
TRENDS IN CELL BIOLOGY (2016)
Therapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseases
Ferenc Sipos et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Immunohistochemical characteristics of basal-like breast cancer
Anna M. Badowska-Kozakiewicz et al.
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY (2016)
BRAFV600E-dependent Mcl-1 stabilization leads to everolimus resistance in colon cancer cells
Kan He et al.
ONCOTARGET (2016)
Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer
Bernardo Queralt et al.
ONCOTARGET (2016)
Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer
Abderrahim El Guerrab et al.
ONCOTARGET (2016)
Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies
Mohammad A. Jafri et al.
GENOME MEDICINE (2016)
Breast Cancer Subtypes: Morphologic and Biologic Characterization
Shahla Masood
WOMENS HEALTH (2016)
Primary and Acquired Resistance of Colorectal Cancer to Anti-EGFR Monoclonal Antibody Can Be Overcome by Combined Treatment of Regorafenib with Cetuximab
Stefania Napolitano et al.
CLINICAL CANCER RESEARCH (2015)
Phase II study of a combination regimen of gefitinib and pemetrexed as first-line treatment in patients with advanced non-small cell lung cancer harboring a sensitive EGFR mutation
Naruo Yoshimura et al.
LUNG CANCER (2015)
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update
Naoko Takebe et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
The Efficacy of Synchronous Combination of Chemotherapy and EGFR TKIs for the First-Line Treatment of NSCLC: A Systematic Analysis
Han Yan et al.
PLOS ONE (2015)
Cancer stem cells and cell size: A causal link?
Qiuhui Li et al.
SEMINARS IN CANCER BIOLOGY (2015)
Signal Transduction in Cancer
Richard Sever et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
RANK Signaling Amplifies WNT-Responsive Mammary Progenitors through R-SPONDINI
Purna A. Joshi et al.
STEM CELL REPORTS (2015)
Erlotinib-Cisplatin Combination Inhibits Growth and Angiogenesis through c-MYC and HIF-1α in EGFR-Mutated Lung Cancer In Vitro and In Vivo
Jasmine G. Lee et al.
NEOPLASIA (2015)
Multicenter randomized, open-label phase II trial of sequential erlotinib and gemcitabine compared with gemcitabine monotherapy as first-line therapy in elderly or ECOG PS two patients with advanced NSCLC
Michael Michael et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2015)
Molecular Classification of Breast Carcinoma: From Traditional, Old-Fashioned Way to A New Age, and A New Way
Nuket Eliyatkin et al.
JOURNAL OF BREAST HEALTH (2015)
HER2 in Breast Cancer: A Review and Update
Uma Krishnamurti et al.
ADVANCES IN ANATOMIC PATHOLOGY (2014)
Progress in detecting cell-surface protein receptors: the erythropoietin receptor example
Steve Elliott et al.
ANNALS OF HEMATOLOGY (2014)
Combined gefitinib and pemetrexed overcome the acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
Min Wui et al.
MOLECULAR MEDICINE REPORTS (2014)
Tackling the cancer stem cells - what challenges do they pose?
Diwakar R. Pattabiraman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Tracking progesterone receptor-mediated actions in breast cancer
Todd P. Knutson et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Epidermal growth factor, from gene organization to bedside
Fenghua Zeng et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)
Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
Suling Liu et al.
STEM CELL REPORTS (2014)
Vascular Endothelial Growth Factor and Angiogenesis in the Regulation of Cutaneous Wound Repair
Kelly E. Johnson et al.
ADVANCES IN WOUND CARE (2014)
Chromogenic in situ hybridization compared with other approaches to evaluate HER2/neu status in breast carcinomas
F. E. Rosa et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2013)
Breast cancer subtypes: response to radiotherapy and potential radiosensitisation
F. E. Langlands et al.
BRITISH JOURNAL OF RADIOLOGY (2013)
Phase II Study of Pemetrexed and Erlotinib in Pretreated Nonsquamous, Non-Small-Cell Lung Cancer Patients without an EGFR mutation
Young Hak Kim et al.
CHEMOTHERAPY (2013)
Derailed Estrogen Signaling and Breast Cancer: An Authentic Couple
Bramanandam Manavathi et al.
ENDOCRINE REVIEWS (2013)
TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
Neil E. Bhola et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
Neal I. Lindeman et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells
Shin-ichiro Ohno et al.
MOLECULAR THERAPY (2013)
Examining the Pathogenesis of Breast Cancer Using a Novel Agent-Based Model of Mammary Ductal Epithelium Dynamics
Joaquin Chapa et al.
PLOS ONE (2013)
Long non-coding RNAs and human X-chromosome regulation A coat for the active X chromosome
Celine Vallot et al.
RNA BIOLOGY (2013)
EGFRvIII Expression in Squamous Cell Carcinoma of the Skin
Piotr J. Dziunycz et al.
JAMA DERMATOLOGY (2013)
Noncoding RNAs in cancer and cancer stem cells
Tianzhi Huang et al.
CHINESE JOURNAL OF CANCER (2013)
Prediction of BRCA1 Germline Mutation Status in Women With Ovarian Cancer Using Morphology-based Criteria Identification of a BRCA1 Ovarian Cancer Phenotype
Mika Fujiwara et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Redox Regulation of Epidermal Growth Factor Receptor Signaling through Cysteine Oxidation
Thu H. Truong et al.
BIOCHEMISTRY (2012)
Epidermal growth factor receptor and K-Ras mutations and resistance of lung cancer to insulin-like growth factor 1 receptor tyrosine kinase inhibitors
Woo-Young Kim et al.
CANCER (2012)
Analysis of Driver Mutations in Female Non-Smoker Asian Patients with Pulmonary Adenocarcinoma
Shengxiang Ren et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2012)
Mitochondrial DNA mutations in respiratory complex-I in never-smoker lung cancer patients contribute to lung cancer progression and associated with EGFR gene mutation
Santanu Dasgupta et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Randomized Phase II Trial of Erlotinib Alone or With Carboplatin and Paclitaxel in Patients Who Were Never or Light Former Smokers With Advanced Lung Adenocarcinoma: CALGB 30406 Trial
Pasi A. Jaenne et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response
Zhao Chen et al.
NATURE (2012)
Signaling Mechanisms Controlling Cell Fate and Embryonic Patterning
Norbert Perrimon et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
TCF/LEFs and Wnt Signaling in the Nucleus
Ken M. Cadigan et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Intrinsic caspase-8 activation mediates sensitization of erlotinib-resistant tumor cells to erlotinib/cell-cycle inhibitors combination treatment
M. Orzaez et al.
CELL DEATH & DISEASE (2012)
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Scott Valastyan et al.
CELL (2011)
Toll-like Receptor 9 Agonist IMO Cooperates with Cetuximab in K-Ras Mutant Colorectal and Pancreatic Cancers
Roberta Rosa et al.
CLINICAL CANCER RESEARCH (2011)
Anti-VEGF Treatment-Resistant Pancreatic Cancers Secrete Proinflammatory Factors That Contribute to Malignant Progression by Inducing an EMT Cell Phenotype
Carmine Carbone et al.
CLINICAL CANCER RESEARCH (2011)
Mammary Development and Breast Cancer: The Role of Stem Cells
C. Ercan et al.
CURRENT MOLECULAR MEDICINE (2011)
Telomeres, lifestyle, cancer, and aging
Masood A. Shammas
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2011)
Modular Anti-EGFR and Anti-Her2 Targeting of SK-BR-3 and BT474 Breast Cancer Cell Lines in the Presence of ErbB Receptor-Specific Growth Factors
Simone Diermeier-Daucher et al.
CYTOMETRY PART A (2011)
HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies
Devika Gajria et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2011)
Analysis of the Mitochondrial Complex I-V Enzyme Activities of Peripheral Leukocytes in Oxidative Phosphorylation Disorders
Yan-Yan Ma et al.
JOURNAL OF CHILD NEUROLOGY (2011)
Minireview: Basal-Like Breast Cancer: From Molecular Profiles to Targeted Therapies
Daniel J. Toft et al.
MOLECULAR ENDOCRINOLOGY (2011)
Deconstructing the molecular portraits of breast cancer
Aleix Prat et al.
MOLECULAR ONCOLOGY (2011)
ERK phosphorylation predicts synergism between gemcitabine and the epidermal growth factor receptor inhibitor AG1478
Peter P. Luk et al.
LUNG CANCER (2011)
Quantification and clinical relevance of gene amplification at chromosome 17q12-q21 in human epidermal growth factor receptor 2-amplified breast cancers
Pierre-Jean Lamy et al.
BREAST CANCER RESEARCH (2011)
Insulin-like Growth Factor 1 Synergizes With Bone Morphogenetic Protein 7-Mediated Anabolism in Bovine Intervertebral Disc Cells
Jae-Sung Kim et al.
ARTHRITIS AND RHEUMATISM (2010)
Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model
Roque Diaz et al.
BMC CANCER (2010)
CSPG4 Protein as a New Target for the Antibody-Based Immunotherapy of Triple-Negative Breast Cancer
Xinhui Wang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Convergence between Wnt-β-catenin and EGFR signaling in cancer
Tianhui Hu et al.
MOLECULAR CANCER (2010)
Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy
Danielle B. Ulanet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
Magali Olivier et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
The Green Tea Polyphenol EGCG Potentiates the Antiproliferative Activity of c-Met and Epidermal Growth Factor Receptor Inhibitors in Non-small Cell Lung Cancer Cells
Shawn A. Milligan et al.
CLINICAL CANCER RESEARCH (2009)
Mechanisms of tumor resistance to EGFR-targeted therapies
Elizabeth A. Hopper-Borge et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Cell biology and physiology of the uroepithelium
Puneet Khandelwal et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
The biology of ovarian cancer: new opportunities for translation
Robert C. Bast et al.
NATURE REVIEWS CANCER (2009)
Aberrant Expression of E-cadherin in Lobular Carcinomas of the Breast
Leonard Da Silva et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Refractoriness to antivascular endothelial growth factor treatment: Role of myeloid cells
Farbod Shojaei et al.
CANCER RESEARCH (2008)
Novel cytotoxic drugs: Old challenges, new solutions
Gustavo F. V. Ismae et al.
CANCER TREATMENT REVIEWS (2008)
The epidermal growth factor receptor family: Biology driving targeted therapeutics
M. J. Wieduwilt et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis
M. M. Moasser
ONCOGENE (2007)
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
Farbod Shojaei et al.
NATURE BIOTECHNOLOGY (2007)
The phosphoinositide 3-kinase pathway in human cancer: Genetic alterations and therapeutic implications
Alexandre Arcaro et al.
CURRENT GENOMICS (2007)
EGFR associated expression profiles vary with breast tumor subtype
Katherine A. Hoadley et al.
BMC GENOMICS (2007)
Heritable skewed X-chromosome inactivation leads to haemophilia A expression in heterozygous females
Nisa K. Renault et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2007)
Lymphomas can develop from B cells chronically helped by idiotype-specific T cells
Michael M. Zangani et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Biological characterization of ARRY-142886 (AZD6244), a potent, highly selective mitogen-activated protein kinase kinase 1/2 inhibitor
Tammie C. Yeh et al.
CLINICAL CANCER RESEARCH (2007)
Analysis of microarray experiments of gene expression profiling
Adi L. Tarca et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2006)
The impact of expression profiling on prognostic and predictive testing in breast cancer
JS Reis et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
PTEN activity could be a predictive marker of trastuzumab efficacy in the treatment of ErbB2-overexpressing breast cancer
T Fujita et al.
BRITISH JOURNAL OF CANCER (2006)
Gene expression patterns and profile changes pre- and post-erlotinib treatment in patients with metastatic breast cancer
SX Yang et al.
CLINICAL CANCER RESEARCH (2005)
Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations
T Mukohara et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Molecular and cellular determinants of estrogen receptor α expression
JJ Pinzone et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Adult cardiac stem cells are multipotent and support myocardial regeneration
AP Beltrami et al.
CELL (2003)
Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres
M Dowsett et al.
JOURNAL OF PATHOLOGY (2003)
Urokinase receptors promote β1 integrin function through interactions with integrin α3β1
Y Wei et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
Mutations in WSC genes for putative stress receptors result in sensitivity to multiple stress conditions and impairment of Rlm1-dependent gene expression in Saccharomyces cerevisiae
T Zu et al.
MOLECULAR GENETICS AND GENOMICS (2001)
The human mitochondrial ribosomal protein genes: Mapping of 54 genes to the chromosomes and implications for human disorders
N Kenmochi et al.
GENOMICS (2001)
Bone marrow cells regenerate infarcted myocardium
D Orlic et al.
NATURE (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas
MH Lyda et al.
HUMAN PATHOLOGY (2000)
分享论文
